Literature DB >> 9003042

Expression of endothelin-converting enzyme in both neuroblastoma and glial cell lines and its localization in rat hippocampus.

K Barnes1, B J Walkden, T C Wilkinson, A J Turner.   

Abstract

Endothelin-converting enzyme is a phosphoramidon-sensitive metalloprotease that cleaves big endothelin to the potent vasoconstrictor peptide, endothelin. The converting enzyme is expressed in endothelial cells in a variety of tissues and in some secretory cells. In the present study, phosphoramidon-sensitive endothelin-converting enzyme activity has been demonstrated by radioimmunoassay in the neuroblastoma cell line, SH-SY5Y, and in Bu17 and C6 glioma lines. The identity of the activity was confirmed by immunoblotting, revealing a polypeptide of approximately 120 kDa in each of these lines, in D384 glioma cells, and in primary astrocytes. Immunofluorescence revealed the cell-surface location of endothelin-converting enzyme in the neuronal and glial cell lines and in primary astrocytes. Pretreatment of SH-SY5Y and Bu17 cells with phosphoramidon resulted in an apparent concentration of the enzyme protein in an intracellular compartment. Immunoperoxidase-staining of rat brain sections located this metalloprotease to the pyramidal cells of the hippocampus. Endothelin-converting enzyme-1 was revealed by in situ hybridisation in the neuronal and glial cell lines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9003042     DOI: 10.1046/j.1471-4159.1997.68020570.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Histochemical distribution of endothelin-converting enzyme subtypes in Podarcis sicula (Squamata, Lacertidae) tissues.

Authors:  Salvatore Valiante; Marina Prisco; Maria De Falco; Francesca Virgilio; Rosaria Sciarrillo; Piero Andreuccetti; Vincenza Laforgia; Lorenzo Varano
Journal:  J Anat       Date:  2005-10       Impact factor: 2.610

Review 2.  Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.

Authors:  Natalia N Nalivaeva; Anthony J Turner
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

Review 3.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

Review 4.  The endothelin system and endothelin-converting enzyme in the brain: molecular and cellular studies.

Authors:  K Barnes; A J Turner
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

5.  Expression of endothelin system in neuroblastic tumors: close association of endothelin-1 and endothelin B receptor expression with differentiation of tumor cells.

Authors:  Nobuo Hoshi; Takashi Sugino; Toshimitsu Suzuki
Journal:  Med Mol Morphol       Date:  2009-06-18       Impact factor: 2.309

Review 6.  Gene therapy in Alzheimer's disease - potential for disease modification.

Authors:  Per Nilsson; Nobuhisa Iwata; Shin-ichi Muramatsu; Lars O Tjernberg; Bengt Winblad; Takaomi C Saido
Journal:  J Cell Mol Med       Date:  2010-02-16       Impact factor: 5.310

Review 7.  New insights into the roles of metalloproteinases in neurodegeneration and neuroprotection.

Authors:  A J Turner; N N Nalivaeva
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

Review 8.  Animal models of stroke.

Authors:  Yanyu Li; Jingjing Zhang
Journal:  Animal Model Exp Med       Date:  2021-09-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.